As the rising cost of medicines ripples around the world, a Canadian government advisory panel is recommending the country create an agency to grapple with high drug prices and also develop a national formulary for insurance coverage, but stopped short of saying whether a universal, single-payer system – known as Pharmacare — should be adopted.

Specifically, the panel suggested such an agency would be chartered with evaluating the clinical evidence and cost-effectiveness of prescription medicines, conducting negotiations with manufacturers over prices, overseeing a formulary, and monitoring safety and effectiveness.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy